Tuberculosis - Annual Epidemiological Report for 2016
Thirty EU/EEA countries reported 58 994 TB cases, 11.4 cases per 100 000 population.
Social determinants and risk factors in tuberculosis surveillance in the EU/EEA
The objective of this report is to provide countries with advice on what social determinant and risk factor variables to collect and what definitions to use, and to propose information to be collected at the national and European level.
Public health guidance on active case finding of communicable diseases in prison settings
This joint guidance from ECDC and the European Monitoring Centre for Drugs and Drug Addiction provides EU/EEA Member States with evidence-based scientific advice on active case finding options. These options can be applied to the planning and implementation of interventions that promote the early diagnosis of communicable diseases in prison settings.
Mathematical modelling of programmatic screening strategies for latent tuberculosis infection in countries with low tuberculosis incidence
Elimination of tuberculosis (TB) requires the management of latent tuberculosis infection (LTBI) in key populations. Thus, people with LTBI need to be diagnosed and treated with appropriate regimens. It is unknown how different screening and treatment strategies of key populations affect TB transmission and progress toward elimination.
Cost-effectiveness analysis of programmatic screening strategies for latent tuberculosis infection in the EU/EEA
The elimination of tuberculosis (TB) in Europe will require the management of latent tuberculosis infection (LTBI) in key populations. Management of LTBI requires the identification and adequate treatment of infected people. It is currently unknown how screening and treatment of key populations should be best organised to have the highest impact with the available resources.
ECDC Calculator - LTBI control in European countries
The ECDC Calculator- LTBI control in European countries is an Excel tool based on a tuberculosis transmission model with the purpose to assess different screening strategies for latent tuberculosis infection (LTBI).
This tool uses data from four pilot countries to estimate annual tuberculosis incidence and to predict the costs and effect of different LTBI screening strategies over a 20-year period.